Correlation Between Nurix Therapeutics and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nurix Therapeutics and Neurocrine Biosciences, you can compare the effects of market volatilities on Nurix Therapeutics and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Neurocrine Biosciences.

Diversification Opportunities for Nurix Therapeutics and Neurocrine Biosciences

-0.63

Correlation Coefficient

Nurix Therapeutics  Neurocrine Biosciences

Excellent diversification

The 3 months correlation between Nurix and Neurocrine is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Nurix Therapeutics and Neurocrine Biosciences

Given the investment horizon of 90 days Nurix Therapeutics is expected to generate 2.59 times more return on investment than Neurocrine Biosciences. However, Nurix Therapeutics is 2.59 times more volatile than Neurocrine Biosciences. It trades about 0.04 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.04 per unit of risk. If you would invest  1,187  in Nurix Therapeutics on October 21, 2024 and sell it today you would earn a total of  727.00  from holding Nurix Therapeutics or generate 61.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nurix Therapeutics  vs.  Neurocrine Biosciences

Nurix Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Neurocrine Biosciences

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nurix Therapeutics and Neurocrine Biosciences

The main advantage of trading using opposite Nurix Therapeutics and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind Nurix Therapeutics and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.